{
    "2021-03-08": [
        [
            {
                "time": "",
                "original_text": "A股头条之上市公司（3.9）",
                "features": {
                    "keywords": [
                        "A股",
                        "上市公司"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "华东医药：MB-102注射液临床试验申请获得受理",
                "features": {
                    "keywords": [
                        "华东医药",
                        "MB-102",
                        "注射液",
                        "临床试验",
                        "申请受理"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "华东医药(000963.SZ)：1类新药MB-102注射液(Relmapirazin)临床试验申请获受理",
                "features": {
                    "keywords": [
                        "华东医药",
                        "新药",
                        "MB-102",
                        "Relmapirazin",
                        "临床试验",
                        "申请受理"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "华东医药(000963.SZ)荧光示踪剂MB-102注射液临床试验申请获受理",
                "features": {
                    "keywords": [
                        "华东医药",
                        "荧光示踪剂",
                        "MB-102",
                        "临床试验",
                        "申请受理"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业一周观察：大小市值表现分化 关注二线优质公司的机会",
                "features": {
                    "keywords": [
                        "医药行业",
                        "市值分化",
                        "二线优质公司",
                        "机会"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "123家公司获机构调研（附名单）",
                "features": {
                    "keywords": [
                        "机构调研",
                        "公司名单"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "华东医药砸20亿对外并购 英国子公司能否扛起“医美”大旗",
                "features": {
                    "keywords": [
                        "华东医药",
                        "20亿",
                        "并购",
                        "英国子公司",
                        "医美"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "医美"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}